Please login to the form below
Clinical trials transparency
This page shows the latest Clinical trials transparency news and features for those working in and with pharma, biotech and healthcare.
Pharma reputation lags behind real value, study suggests
The main factors in pharma’s negative public perception included public drug price debates with the NHS, Brexit stockpiling uncertainties, executive pay, and a lack of transparency over clinical trials. ... At the same time, the Portland survey points
Latest news
-
AllTrials tracker site names clinical trial non-reporters
Organisations that fail to report the results of their clinical trials are to be named on a new website set up by the AllTrials campaign group. ... The results of clinical trials are being routinely withheld from doctors, researchers, and patients,”
-
Nearly half of all clinical trials not published
Around half of all trials run by pharma companies, universities and other major research sponsors remain unpublished, according to a tool built to promote greater trial transparency. ... EFPIA supports the intent of the new EU Clinical Trials Regulation
-
Safeguarding European research
Increased transparency with regard to clinical trials and their outcomes is also one of the mainstays of the new Regulation. ... Industry supports the provisions related to disclosure of information on clinical trials under the Regulation.
-
Daiichi Sankyo begins sharing clinical trial data online
The Clinical Study Data Request website was spearheaded in 2013 by GlaxoSmithKline, which lists on the site 1, 700 clinical trials dating back to the company's formation in 2000. ... Since May 2013 the AllTrials transparency campaign says data have been
-
WHO calls for publication of previously unreported studies
The World Health Organization has joined the debate about clinical transparency with a call to make all trial results publicly available. ... This will ensure transparency as to which clinical trials have occurred, and allow verification of compliance
More from news
Approximately 4 fully matching, plus 22 partially matching documents found.
Latest Intelligence
-
From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement. In 2014, the European Medicines Agency (EMA) gave the first indication that layperson summaries of the results of pharma-sponsored clinical trials ... This was part of a drive towards
-
Retaining reader value in plain language summaries of clinical studies
From 2019, sponsors of clinical research will need to prepare plain-language summaries (PLSs) for all phase 1-4 interventional trials, to fulfil requirements for greater transparency under EU Clinical Trials ... Practice makes perfect. For now, summaries
-
Clinical trial regulation in Mexico
Clinical trials in Mexico. Mexico stands out among many other clinical trial outsourcing destinations both for speed and cost savings. ... There are many well qualified, US-trained physicians in Mexico who could lead successful clinical trials.
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Clinical data Transparency
But despite simplistic reporting, the issue of increasing the transparency of data from clinical trials contains complexities not often addressed. ... Transparency of clinical trials data and other research is an important issue and it is therefore
-
PRA International
A leading global CRO, PRA is transforming clinical trials through our people, innovation and transparency.
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Pharmacovigilance Manager
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
- MHRA to introduce new UK clinical trials framework
- Sanofi/Regeneron’s Dupixent approved by EC for atopic dermatitis in children
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Inizio appoints Stefanie Christmas as global head of DE&I
- Rare diseases: not so rare after all
- Sanofi/Regeneron’s Dupixent shows promise in atopic hand and foot dermatitis
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Biogen and Eisai’s Alzheimer’s drug to be covered by US Veterans Health Administration
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Dermavant reports positive phase 3 results for Vtama cream in atopic dermatitis
- Pfizer/BioNTech’s Omicron-adapted booster approved by FDA for young children
- Havas Health & You appoints Alex Okada as chief creative officer of Havas Lynx Group
PMHub
Fishawack Health
Established in 2001, Fishawack Health (FH) is a purposefully built commercialization partner for the biopharmaceutical, medical technology, and wellness industries....
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
